CIK: 1617236 - Address: C/O Immunovant, Inc., 320 W 37Th Street, 6Th Floor, New York, NY 10018
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1112-5-9-3800-13
S%wins010010010075

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/22/24 16:12
11/20/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-9325.450-4-1319D
10/25/24 16:25
10/23/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-12929.530-4-1323D
10/18/24 16:28
10/16/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-8228.790-3-1327D
8/23/24 16:15
8/21/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-10531.860-3-1330D
7/26/24 16:17
7/24/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-11127.760-4-1333D
7/19/24 17:42
7/17/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-7429.690-3-1337D
5/24/24 16:10
5/22/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-9629.650-3-1340D
4/26/24 17:18
4/24/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-11528.900-4-1343D
4/19/24 18:06
4/17/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-28629.060-10-3347D
2/23/24 16:18
2/22/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-7736.150-2-1302D
1/29/24 16:12
1/26/24
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-11537.920-3-1304D
11/24/23 14:41
11/22/23
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-10732.780-3-1307D
10/27/23 16:04
10/25/23
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-14234.660-4-1310D
8/25/23 17:05
8/24/23
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-24920.300-12-4314D
7/27/23 16:33
7/26/23
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-8521.630-4-1327D
4/26/23 16:08
4/25/23
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-4316.290-3-1331D
1/27/23 07:20
1/26/23
IMVTImmunovant, Inc.DEHealthBioPrdBiological Products, (No DiagLevine Mark S.NYOGCS-18818.510-10-4246D
7/20/21 20:45
7/19/21
FLXNFlexion Therapeutics IncDEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOGCS-256.450-4-3133D
1/7/21 17:52
1/5/21
FLXNFlexion Therapeutics IncDEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOGCS-7611.130-7-6107D
1/7/20 16:35
1/3/20
FLXNFlexion Therapeutics IncDEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOGCS00.000-4-843D
1/4/19 17:12
1/3/19
FLXNFlexion Therapeutics IncDEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOGCS-912.360-1-79D
6/5/17 16:33
6/1/17
NERVMinerva Neurosciences, Inc.DEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOSVP,GC,SM.d915.190180D
6/5/17 16:33
6/1/17
NERVMinerva Neurosciences, Inc.DEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOSVP,GC,SS.d-19311.000-18-1000D
1/6/17 16:28
1/4/17
NERVMinerva Neurosciences, Inc.DEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOSVP,GC,SM.d834.723180D8711414-15-11-10-532-5-9-38
1/6/17 16:28
1/4/17
NERVMinerva Neurosciences, Inc.DEHealthDrugPharmaceutical PreparationsLevine Mark S.MAOSVP,GC,SS.d-21012.003-18-1000D8711414-15-11-10-532-5-9-38

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact